AP31969
/ Acesion
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
November 04, 2024
Single Ascending Dose, Multiple Ascending Dose, Food Effect Study with AP31969
(clinicaltrials.gov)
- P1 | N=124 | Recruiting | Sponsor: Acesion Pharma | Trial completion date: Sep 2024 ➔ Feb 2025 | Trial primary completion date: Sep 2024 ➔ Feb 2025
Trial completion date • Trial primary completion date
May 07, 2024
Single Ascending Dose, Multiple Ascending Dose, Food Effect Study With AP31969
(clinicaltrials.gov)
- P1 | N=124 | Recruiting | Sponsor: Acesion Pharma | Trial completion date: May 2024 ➔ Sep 2024 | Trial primary completion date: May 2024 ➔ Sep 2024
Trial completion date • Trial primary completion date
November 27, 2023
Single Ascending Dose, Multiple Ascending Dose, Food Effect Study With AP31969
(clinicaltrials.gov)
- P1 | N=124 | Recruiting | Sponsor: Acesion Pharma | Not yet recruiting ➔ Recruiting
Enrollment open
October 04, 2023
Single Ascending Dose, Multiple Ascending Dose, Food Effect Study With AP31969
(clinicaltrials.gov)
- P1 | N=124 | Not yet recruiting | Sponsor: Acesion Pharma
New P1 trial
1 to 4
Of
4
Go to page
1